CMMB logo

Chemomab Therapeutics (CMMB) EBITDA

Annual EBITDA

-$14.74 M
+$10.65 M+41.95%

December 1, 2024


Summary


Performance

CMMB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMMBprofitabilitymetrics:

Quarterly EBITDA

-$3.21 M
+$497.00 K+13.40%

December 1, 2024


Summary


Performance

CMMB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMMBprofitabilitymetrics:

TTM EBITDA

-$14.74 M
+$635.00 K+4.13%

December 1, 2024


Summary


Performance

CMMB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMMBprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CMMB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+42.0%0.0%0.0%
3 y3 years-19.5%0.0%0.0%
5 y5 years-147.8%0.0%0.0%

CMMB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.5%+48.2%at high+64.4%-19.5%+56.8%
5 y5-year-147.8%+48.2%-193.2%+64.4%-767.5%+56.8%
alltimeall time-147.8%+48.2%-193.2%+64.4%-767.5%+56.8%

Chemomab Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$14.74 M(-42.0%)
-$3.21 M(-13.4%)
-$14.74 M(-4.1%)
Sep 2024
-
-$3.71 M(-1.5%)
-$15.37 M(-4.1%)
Jun 2024
-
-$3.77 M(-6.9%)
-$16.03 M(-21.6%)
Mar 2024
-
-$4.05 M(+5.2%)
-$20.44 M(-19.6%)
Dec 2023
-$25.39 M(-10.8%)
-$3.85 M(-11.9%)
-$25.43 M(-15.8%)
Sep 2023
-
-$4.37 M(-46.6%)
-$30.21 M(-11.5%)
Jun 2023
-
-$8.18 M(-9.5%)
-$34.14 M(+6.0%)
Mar 2023
-
-$9.03 M(+4.7%)
-$32.20 M(+13.1%)
Dec 2022
-$28.48 M
-$8.63 M(+4.0%)
-$28.48 M(+14.5%)
Sep 2022
-
-$8.30 M(+33.0%)
-$24.86 M(+27.9%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$6.24 M(+17.6%)
-$19.44 M(+21.9%)
Mar 2022
-
-$5.31 M(+5.9%)
-$15.95 M(+29.3%)
Dec 2021
-$12.33 M(+107.3%)
-$5.01 M(+73.9%)
-$12.33 M(+33.2%)
Sep 2021
-
-$2.88 M(+5.0%)
-$9.26 M(+21.9%)
Jun 2021
-
-$2.75 M(+62.3%)
-$7.59 M(+27.8%)
Mar 2021
-
-$1.69 M(-12.6%)
-$5.94 M(-0.1%)
Dec 2020
-$5.95 M
-$1.94 M(+59.1%)
-$5.95 M(+48.3%)
Sep 2020
-
-$1.22 M(+11.0%)
-$4.01 M(+43.5%)
Jun 2020
-
-$1.10 M(-35.5%)
-$2.79 M(+64.5%)
Mar 2020
-
-$1.70 M
-$1.70 M

FAQ

  • What is Chemomab Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Chemomab Therapeutics?
  • What is Chemomab Therapeutics annual EBITDA year-on-year change?
  • What is Chemomab Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Chemomab Therapeutics?
  • What is Chemomab Therapeutics quarterly EBITDA year-on-year change?
  • What is Chemomab Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Chemomab Therapeutics?
  • What is Chemomab Therapeutics TTM EBITDA year-on-year change?

What is Chemomab Therapeutics annual EBITDA?

The current annual EBITDA of CMMB is -$14.74 M

What is the all time high annual EBITDA for Chemomab Therapeutics?

Chemomab Therapeutics all-time high annual EBITDA is -$5.95 M

What is Chemomab Therapeutics annual EBITDA year-on-year change?

Over the past year, CMMB annual EBITDA has changed by +$10.65 M (+41.95%)

What is Chemomab Therapeutics quarterly EBITDA?

The current quarterly EBITDA of CMMB is -$3.21 M

What is the all time high quarterly EBITDA for Chemomab Therapeutics?

Chemomab Therapeutics all-time high quarterly EBITDA is -$1.10 M

What is Chemomab Therapeutics quarterly EBITDA year-on-year change?

Over the past year, CMMB quarterly EBITDA has changed by $0.00 (0.00%)

What is Chemomab Therapeutics TTM EBITDA?

The current TTM EBITDA of CMMB is -$14.74 M

What is the all time high TTM EBITDA for Chemomab Therapeutics?

Chemomab Therapeutics all-time high TTM EBITDA is -$1.70 M

What is Chemomab Therapeutics TTM EBITDA year-on-year change?

Over the past year, CMMB TTM EBITDA has changed by $0.00 (0.00%)